Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 02 Jan 2026

Neoantigen immune responses in healthy volunteers: insights from multiple integrated keyhole limpet hemocyanin challenge studies on repeated immunization and response covariates

in Inflammation Pharmacology

Micha N. Ronner
Marieke L. De Kam
Silke Van Reeuwijk
Jacobus Burggraaf
Manon A. A. Jansen
Matthijs Moerland

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1717333

155 views

Original Research

Accepted on 29 Dec 2025

Partially Hydrolyzed Formula with High sn-2 Palmitic Acid on Eosinophils and Outcomes in Preterm Infants: PRIOR Secondary Analysis

in Inflammation Pharmacology

Jialu Zhuang
Ye Liu
Qiongyu Liu
Jiaan Wang
Songlin Liu
Jing Wu
Yanqing Shen
Xuemin Wang
Hui Zhang
Li Yuan

Frontiers in Pharmacology

100 views

Review

Accepted on 29 Dec 2025

Glutathione and Neurodegenerative Diseases: Immunopharmacological Implications

in Inflammation Pharmacology

Ethan Knudsen
Jason Tadje
Carter Coggins
Vishwanath Venketaraman

Frontiers in Pharmacology

Original Research

Accepted on 25 Dec 2025

Multi-omics Integration and Machine Learning-Driven Construction of an Immunogenic Cell Death Prognostic Model for Colon Cancer and Functional Validation of FCGR2A

in Inflammation Pharmacology

Haipeng wang
Ningning chen
Weijia Wang

Frontiers in Pharmacology

Review

Accepted on 24 Dec 2025

MOLECULAR AND PATHOPHYSIOLOGICAL INTERSECTIONS BETWEEN ARTERIAL HYPERTENSION, PULMONARY INFLAMMATION AND DIABETES MELLITUS

in Inflammation Pharmacology

Higo José Neri da Silva
Antônio Carlos Melo Lima Filho
Ester Miranda Pereira
Ian Jhemes Oliveira Sousa
Francisco Valmor Macedo Cunha
Massimo Lucarini
Alessandra Durazzo
Leonardo da Rocha Sousa
Daniel Dias Rufino Arcanjo

Frontiers in Pharmacology

Original Research

Accepted on 22 Dec 2025

Characterization and Anti-inflammatory Studies Based on Supramolecular Assemblies Formed by Chlorogenic Acids and Metal Ions

in Inflammation Pharmacology

Zhen-Min Zhang
Ru-Yue Zhang
Lian Zhu
Zi-Xuan Liu
Han-Xiu Deng
Jiefu Tang
Jiayu Zhang
Wei Cai

Frontiers in Pharmacology

Original Research

Published on 19 Dec 2025

Oleanolic acid cubic liquid crystal nanoparticle-based thermosensitive gel attenuates knee osteoarthritis symptoms in rats

in Inflammation Pharmacology

Zhiqi Shi
Fan Jia
Xiaoyu Tang
Qing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1730566

583 views

Original Research

Published on 18 Dec 2025

Inflammatory response in CF airway epithelial cells: a comparative study of modulators and wild-type CFTR rescue

in Inflammation Pharmacology

Amal Kouadri
Camille Lyko
Carine El Hajjar
Johanna Cormenier
Kevin Kevin Gemy
Nadia Alfaidy
Mohamed Benharouga

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1657688

417 views

Systematic Review

Accepted on 17 Dec 2025

Knowledge Domain and Evolutionary Trends of P2Y Receptors in Cardiovascular Diseases: A Bibliometric and Altmetric Analysis

in Inflammation Pharmacology

Mengyu Yang
Xuanrui Chen
Shiyin Lie
Jingjing Li
Xuezhang Chen
Ju Chen
Zhiqiang Zhang
Liming Lu
Jingchun Zeng

Frontiers in Pharmacology

122 views

General Commentary

Accepted on 15 Dec 2025

Commentary: CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation

in Inflammation Pharmacology

Wentao Guo
Yun Wang
Danqin Fang
Zhihui Zeng

Frontiers in Pharmacology

120 views

Review

Accepted on 12 Dec 2025

κ-Opioid Receptor:From Analgesic Target to Neuroimmune Hub

in Inflammation Pharmacology

Qinsi Tan
Mengjin Zheng
Huaixin Xing

Frontiers in Pharmacology

174 views

Review

Accepted on 11 Dec 2025

Advances in pulmonary neuroendocrine cells and their cellular interactions in asthma pathogenesis

in Inflammation Pharmacology

Lanlan Wang
Hui Wang
Yamei Yuan
Weidong Ye
Xiangming Fang

Frontiers in Pharmacology

136 views

Original Research

Published on 10 Dec 2025

Isoliensinine confers neuroprotection and alleviates LPS-induced neuroinflammation in microglia by regulating the MAPK/NF-κB signaling

in Inflammation Pharmacology

Mengqin Yuan
Jinda Hu
Lichen Gao
Wei Long
Sirui Wang
Xinyue Tan
Jinyue Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1675865

630 views

Review

Published on 10 Dec 2025

Immune modulation in inflammatory bowel disease: therapeutic promise of baicalein

in Inflammation Pharmacology

Yang Wang
Luyao Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1723606

882 views

Review

Accepted on 09 Dec 2025

Molecular insights into NLRP3 inflammasome and miRNA modulation in oral cancer

in Inflammation Pharmacology

Deborah Mannino
Morena D'Ariano
Ivana Bello
Irene Paterniti
Giovanna Casili
Elisabetta Panza

Frontiers in Pharmacology

243 views

Review

Accepted on 08 Dec 2025

Cycloastragenol in Inflammation-Related Diseases: Mechanisms, Pharmacokinetics, and Translational Prospects

in Inflammation Pharmacology

Chun Zhao
Xiuhua Yang
Man Yao
Xiaoxuan Song
Pilong He

Frontiers in Pharmacology

138 views

Systematic Review

Published on 04 Dec 2025

Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis

in Inflammation Pharmacology

Huanmin Kang
Xue Wu
Hanyue Xu
Yufan Huang
Ming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1694311

780 views

Mini Review

Published on 04 Dec 2025

CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases

in Inflammation Pharmacology

Hongzhi Yang
Yanli Wang
Yulong Xu
Changning Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1678159

856 views

Review

Published on 03 Dec 2025

Dapansutrile in multidisciplinary therapeutic applications: mechanisms and clinical perspectives

in Inflammation Pharmacology

Fuwei Bai
Dongyang Wang
Yingying Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1731165

884 views

Original Research

Published on 03 Dec 2025

The clinical value of PLR, NLR, and MLR in predicting mortality risk in hospitalized patients

in Inflammation Pharmacology

Guoxiang Fang
Yunfei Mo
Yangwen Bao
Chunbiao Gao
Qiuya Pan
Tongbo Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1736947

748 views

Opinion

Published on 02 Dec 2025

CCR5-targeted γδ CAR-T cells: a rational step toward HIV-resistant allogeneic immunotherapy

in Inflammation Pharmacology

Lina Hu
Haiyan Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1734423

633 views

Original Research

Published on 01 Dec 2025

Acetyl-11-keto-beta-boswellic acid ameliorates monosodium iodoacetate-induced osteoarthritis in rats: implications of HMGB1/TLR4/NF-κB and Nrf2/HO-1

in Inflammation Pharmacology

Hagar B. Abo-Zalam
Abdallah M. Gendy
Bassam Mohamed Ali
Ghada M. Ragab
Heba Mohammed Refat M. Selim
Najat O. Hamed
Fatemah A. Alherz
Asmaa Saleh
Einas M. Yousef
Amira A. El-Gazar

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1694803

997 views

Review

Accepted on 30 Nov 2025

Flavonoids in inflammatory bowel disease: Multi-dimensional mechanisms via modulation of the intestinal barrier-microbiota-immune axis

in Inflammation Pharmacology

Haodong Cui
Zhilei Li
Huan Dong
Zhuo Liu

Frontiers in Pharmacology

126 views

Original Research

Published on 28 Nov 2025

Omega 3 fatty acid docosahexaenoic acid (DHA) mitigates inflammatory responses in experimental sepsis

in Inflammation Pharmacology

Bianca Portugal Tavares de Moraes
Isabelle Moraes-de-Souza
Gabrielle Lacerda de Souza Gomes-Reis
Marina Ferreira-Costa
Carolina Medina Coeli da Cunha
Matheus Augusto Patrício de Almeida
Vanessa Estato
Kauê Francisco Corrêa Souza e Souza
Francisco da Silva dos Santos
Maria Alice dos Santos Mascarenhas Brito

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1708348

1,189 views

1,831 articles

articles

Neoantigen immune responses in healthy volunteers: insights from multiple integrated keyhole limpet hemocyanin challenge studies on repeated immunization and response covariates

Partially Hydrolyzed Formula with High sn-2 Palmitic Acid on Eosinophils and Outcomes in Preterm Infants: PRIOR Secondary Analysis

Glutathione and Neurodegenerative Diseases: Immunopharmacological Implications

Multi-omics Integration and Machine Learning-Driven Construction of an Immunogenic Cell Death Prognostic Model for Colon Cancer and Functional Validation of FCGR2A

MOLECULAR AND PATHOPHYSIOLOGICAL INTERSECTIONS BETWEEN ARTERIAL HYPERTENSION, PULMONARY INFLAMMATION AND DIABETES MELLITUS

Characterization and Anti-inflammatory Studies Based on Supramolecular Assemblies Formed by Chlorogenic Acids and Metal Ions

Oleanolic acid cubic liquid crystal nanoparticle-based thermosensitive gel attenuates knee osteoarthritis symptoms in rats

Inflammatory response in CF airway epithelial cells: a comparative study of modulators and wild-type CFTR rescue

Knowledge Domain and Evolutionary Trends of P2Y Receptors in Cardiovascular Diseases: A Bibliometric and Altmetric Analysis

Commentary: CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation

κ-Opioid Receptor:From Analgesic Target to Neuroimmune Hub

Advances in pulmonary neuroendocrine cells and their cellular interactions in asthma pathogenesis

Isoliensinine confers neuroprotection and alleviates LPS-induced neuroinflammation in microglia by regulating the MAPK/NF-κB signaling

Immune modulation in inflammatory bowel disease: therapeutic promise of baicalein

Molecular insights into NLRP3 inflammasome and miRNA modulation in oral cancer

Cycloastragenol in Inflammation-Related Diseases: Mechanisms, Pharmacokinetics, and Translational Prospects

Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis

CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases

Dapansutrile in multidisciplinary therapeutic applications: mechanisms and clinical perspectives

The clinical value of PLR, NLR, and MLR in predicting mortality risk in hospitalized patients

CCR5-targeted γδ CAR-T cells: a rational step toward HIV-resistant allogeneic immunotherapy

Acetyl-11-keto-beta-boswellic acid ameliorates monosodium iodoacetate-induced osteoarthritis in rats: implications of HMGB1/TLR4/NF-κB and Nrf2/HO-1

Flavonoids in inflammatory bowel disease: Multi-dimensional mechanisms via modulation of the intestinal barrier-microbiota-immune axis

Omega 3 fatty acid docosahexaenoic acid (DHA) mitigates inflammatory responses in experimental sepsis